Blood and urinary tests in stone formers

Urinary Tract Stone Disease

Volumn , Issue , 2011, Pages 369-374

  Semins, Michelle Jo ^a   Matlaga, Brian R ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880922562     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-362-0_31     Document Type: Chapter

References (20)

1. Levy FL, Adams-Huet B, Pak C Y C. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50.
2. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817.
3. Heilberg IP, Schor N. Renal stone disease: causes, evaluation, and medical treatment. Arq Bras Endocrinol Metab. 2006;50:823.
4. Scales CD, Curtis LH, Norris RD, et al. Changing gender prevalence of stone disease. J Urol. 2007;177:979.
5. Prezioso D, DiMartino M, Galasso R, et al. Laboratory assessment. Urol Int. 2007;79:20.
6. Odvina CV, Pak C Y C. Medical evaluation of stone disease. in: Stoller ML, Men MV, eds. Current Clinical Urology. Urinary Stone Disease: A Practical Guide to Medical and Surgical Management, vol. 1. Totowa: Humana; 2007.
7. Pearle MS, Calhoun EA, Curha GC, et al. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848.
8. Lotan Y, Cadeddu JA, Pearle MS. International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res. 2005;33:223.
9. Begun FP, Foley WD, Peterson A, et al. Patient evaluation laboratory and imaging studies. In: Resnick M, ed. The Urologic Clinics of North America, Urolithiasis, vol. 24. Philadelphia: W. B. Saunders; 1997:97-116.
10. Preminger GM. Medical evaluation and treatment of nephrolithiasis. Semin Urol. 1994;12:51.
11. Pak C Y C, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69:19.
12. DeFoor W, Asplin J, Jackson E, et al. Urinary metabolic evaluations in normal and stone forming children. J Urol. 2006;176:1793.
13. DeFoor W, Minevich E, Jackson E, et al. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol. 2008;179:2369.
14. Pak C Y C, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol. 2001;165:378.
15. Parks JH, Goldfisher E, Asplin JR, et al. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002;167:1607.
16. Porena M, Guiggi P, Micheli C. Prevention of stone disease. Urol Int. 2007;79:37.
17. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol. 2001;12:1986.
18. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996;156:907.
19. Coe FL, Kavlach AG. Hypercalciuria and hyperuiicosuria in patients with calcium nephrolithiasis. NEngl J Med. 1974;291:1344.
20. Hesse A, Vahlensieck W. Loading tests for diagnosis of metabolic anomalies in urinary stone formers. Int Urol Nephrol. 1986;18:45.